Hypertension, or high blood pressure, is a significant risk factor for atrial fibrillation, with studies showing that it is present in about 70% AF patients. While the relationship between AF and hypertension is complex, it may alter the structure of the heart, leading to the development of AF.

Learn about the role of genetics in atrial fibrillation (AF) and how identifying AF-associated genes can help us understand why AF happens and potentially lead to genetic therapies for AF.

Learn about the potential use of artificial intelligence (AI) chatbots in supporting patients before and after their ablation procedures. Check out our test 'chatbot' at www.barts.ai and share your feedback!

Learn about the risks of atrial fibrillation (AF) in young adults, the most significant risk factors, and how to address and manage them for a healthier life.

The CAST trial was designed to test whether anti-arrhythmic drugs could reduce the risk of death by suppressing ventricular ectopics in patients after a heart attack.

Learn how an echo, an ultrasound-based imaging assessment of the heart, can provide valuable information for the management of atrial fibrillation. Find out what your doctor is looking for in your echo results and how they can influence your treatment plan.

Discover the best way to manage new-onset AF in the A&E. Is cardioversion necessary, or is a 'wait and see' approach just as effective? Read on to learn more.

Learn about the different rate-control drugs available to manage atrial fibrillation, including beta-blockers, calcium channel blockers, and digoxin. Discover the latest evidence from the RATE-AF study and find out which drug might be the best choice for different patient groups.